In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback